Background and aim Creating potential clinical markers for risk assessment in patients with COVID-19 continues to be an area of interest. In this study, we aimed to evaluate whether serum albumin level and thrombocyte/lymphocyte ratio are related to the severity of the disease. Materials and methods The patients were divided into two groups according to the severity of disease. Demographic data, serum albumin value, lymphocyte count, TLO-1 values (thrombocyte/lymphocyte ratio-1), the highest thrombocyte count during hospitalization, TLO-2 (thrombocyte/lymphocyte ratio-2) values formed by the highest thrombocyte count, were recorded. Results There was no statistically significant differences (P > 0.05) in terms of sex, thrombocyte count at the time of admission, and highest thrombocyte count during hospital follow-up. There were statistically significant differences in terms of age, comorbidity, lymphocyte value at the time of hospitalization, lymphocyte count during hospital follow-up, TLO 1, TLO 2, and serum albumin values between the groups. The ICU group were found to be older, had higher rates of comorbidity, lower lymphocyte values, higher TLO 1-2, and lower serum albumin levels (P < 0.05). Conclusion TLO-2 ratio above 260 and lymphocyte level below 1 103 cells/μL, would be a predictor of further intensive care unit need.
【저자키워드】 Severity of COVID 19, platelet lenfosit ratio, serum albumin value, 【초록키워드】 intensive care, Hospitalization, severity, hospital, Comorbidity, Sex, risk, ICU, Risk assessment, Lymphocyte count, lymphocyte, Patient, albumin, age, Follow-up, Severity of disease, serum albumin, demographic, Admission, thrombocyte, an area, Older, two groups, demographic data, statistically significant difference, material, clinical markers, Result, highest, evaluate, the disease, two group, groups, were recorded, area of interest, clinical marker, patients with COVID-19, 【제목키워드】 severity, COVID, Prognostic factor,